The University of Louisville today announced that researcher Dr. Suzanne Ildstad, representing Regenerex LLC, has entered into a license and research collaboration agreement with Novartis to provide access to stem cell technology that has the potential to help transplant patients avoid taking anti-rejection medicine for life and could serve as a ... (more)
http://www.eurekalert.org/pub_releases/2013-10/uol-uol103013.php
http://www.eurekalert.org/pub_releases/2013-10/uol-uol103013.php
No comments:
Post a Comment